Imprivata Privileged Access Management

Name: Imprivata Privileged Access Management
Brand: Imprivata
Rating: 4.5 (43 reviews)

Simple and secure access management for mission-critical industries

Est 2000|Valuation $492.5M|Raised $2.6B

LinkedIn 28K|Website|Web traffic 466K|FTEs 833|HQ Waltham, Massachusetts, US

MarketsPrivileged Access Management (PAM)Identity Provider (IdP) & Single Sign-On (SSO)Privileged Access Management (PAM)

Published Sep 26, 2026

01Common complaints

1) If the primary requirement is endpoint least privilege and privilege elevation (PEDM) as a core capability — consider vendors focused on endpoint privilege management. 2) If the requirement is the broadest enterprise PAM ecosystem and marketplace integrations for large legacy environments — evaluate enterprise benchmark vendors with proven track records in large infrastructure estates. 3) If the main need is developer‑focused secrets management for applications and CI/CD pipelines — consider dedicated secrets management platforms. 4) If the organization cannot absorb additional costs for managed services or premium support and requires a low‑touch, self‑service pricing model — evaluate alternative vendors or managed service providers that match the desired operating model.

Deal disqualifiers (poor fit)

Organizations that require full endpoint privilege elevation and delegation management (PEDM) within the same product
Organizations seeking transparent, self‑serve SaaS pricing with month‑to‑month purchasability
DevOps teams that prioritize developer‑centric secrets automation in CI/CD and Kubernetes without additional integration

Limitations noted in third‑party material

A third‑party product description indicates the vendor PAM offering is agentless, supports RDP/SSH workflows, and does not provide full privilege elevation and delegation management (PEDM). Confirm whether this limitation applies to the intended deployment and whether endpoint privilege requirements will need a complementary solution.

Roadmap visibility

The vendor publishes public roadmap materials that can provide signals about planned capabilities. Public roadmaps are marketing‑level artifacts and are not contractual commitments.

Practical operational limitations (inferred from community discussions)

Complex environments (VDI, shared workstations, healthcare kiosks) can require careful policy tuning and troubleshooting to reach stable operations.

Why some customers left for competitors (churn reasons)

Direct public examples of churn from Imprivata PAM to specific competitors were not found in the accessible sources. Typical drivers in the PAM category (based on broader market patterns) include:

Need for more extensive privileged session management, endpoint privilege elevation, or comprehensive secrets automation
Preference for cloud‑native, developer‑centric secrets management
Cost and perceived mismatch between price and scope

02Why they buy

Differentiation supported by market evidence

Vendor presence in healthcare identity and workstation workflows provides operational continuity for organizations already standardized on the vendor’s identity products.
Portfolio coverage that includes internal PAM plus vendor/third‑party access products can reduce the need to integrate multiple vendors to address both internal and external privileged access.

Areas where competitors may have advantages

CyberArk: enterprise breadth and marketplace ecosystem
BeyondTrust / other vendors: stronger endpoint privilege elevation and delegation management capabilities

Why customers chose this product over alternatives (inferred)

Buyers in healthcare ecosystems may prefer a vendor already used for identity workflows and extend to PAM for credential management rather than adopting a separate PAM vendor.
Buyers with significant third‑party access requirements may value the vendor’s VPAM/CPAM adjacency.

Note: these inferences are based on product portfolio alignment and public messaging; direct comparative quotes from customers were not consistently available.

03Field reports

Review platform availability note

Gartner Peer Insights lists a product entry for Imprivata PAM, though some content may be gated. G2 and TrustRadius listings for Imprivata PAM were not reliably accessible in the collected sources (possible reasons include product naming variations and listing fragmentation). Where direct review quotes for Imprivata PAM are limited, this assessment incorporates relevant community discussions and vendor trial materials as context.

What positive feedback tends to emphasize

1) Fit with healthcare operational workflows: community signals related to Imprivata’s broader identity products suggest perceived operational suitability in hospital and shared workstation contexts. 2) Relatively straightforward deployment and a short trial offering: vendor materials and some user commentary indicate deployments may be quicker than some larger PAM suites, which can be a procurement consideration for organizations needing faster time to initial capability. 3) Value of portfolio adjacency for vendor access: organizations that need both internal PAM and vendor/third‑party access controls may see value in a common vendor portfolio that covers both use cases.

Common criticisms and complaints (from accessible discussions)

Publicly accessible negative signals are more prevalent for Imprivata’s broader identity/workstation products than for PAM specifically; however, available critiques relevant to PAM and adjacent deployments include: 1) Integration and configuration complexity in virtual desktop or shared workstation environments (Kerberos, keytab configuration, client/service state issues). 2) Support and managed services cost sensitivity reported in community discussions; managed services may represent a meaningful additional cost. 3) Perception by some reviewers that pricing can be high relative to the provided scope when the expectation is for a broader feature set (for example, session management or endpoint privilege elevation in a single product).

Vendor‑published case studies

The vendor hosts PAM case study material that references customer reviews and review extracts as a source of outcomes. Where metrics originate from a single end‑user review or are curated from review narratives, they should be treated as self‑reported and not independently audited.

Critical evaluation: use these materials as indicative of customer experience in similar contexts, but validate claimed outcomes through reference checks and operational metrics where possible.

Ecosystem case studies (VPAM / privileged access security)

Vendor case studies related to privileged access security often focus on vendor/third‑party access modernization and may reflect VPAM/CPAM functionality more than internal credential vaulting. Distinguish case study claims that relate to vendor access from those that relate to internal PAM outcomes.

04Best fit

Company sizes

Typical fit: mid‑market to enterprise organizations with regulated workloads and material privileged account sprawl, including health systems and large regulated enterprises. Practical range: organizations ranging from mid‑market firms to very large enterprises depending on organizational structure and the number of privileged accounts.

Industries / verticals

Healthcare providers and healthcare IT vendors
Other regulated industries (government, legal, financial services, etc.) where auditable privileged credential controls are required

Roles and personas

CISO / Head of Security
IAM/PAM program owner
Infrastructure / security engineering teams
Compliance and audit teams
Vendor/third‑party risk and vendor management teams (for VPAM/CPAM use cases)

Qualification criteria (good fit)

Organizations that already use the vendor for adjacent identity or workstation workflows and wish to consolidate vendors
Organizations that require auditable credential controls (rotation, workflows) and prefer a comparatively straightforward operational model
Deployments where third‑party vendor access governance is a major driver and the vendor’s VPAM/CPAM modules are relevant

05The pitch

What the product does (core value proposition)

Imprivata Privileged Access Management (PAM) is a privileged credential and access control product intended to secure, rotate, and govern privileged/shared credentials (for example, administrative passwords and service account credentials) and to provide auditing and workflow controls. Vendor materials describe the product as focused on straightforward deployment and operational workflows, with specific applicability to regulated environments such as healthcare. The product is part of a broader Privileged Access Security portfolio that includes vendor/third‑party access functionality. Key capabilities emphasized in vendor materials include: - Privileged credential discovery and inventory - Secure vaulting and automated password rotation - Just‑in‑time and time‑bound access workflows - Credential checkout workflows and one‑time‑use credential generation - Monitoring and auditing of privileged activity (reporting depth varies by module) - Alignment with Zero Trust concepts (policy enforcement and auditability)

Target market and market positioning

Imprivata has a history of deployments in healthcare identity workflows (badge tap, fast user switching, clinician workstation workflows). The PAM product is positioned for: - Healthcare and other regulated industries that require auditable control of privileged credentials - Organizations seeking a PAM solution that vendors describe as relatively straightforward to deploy compared with larger enterprise suites - Environments that also require vendor privileged access (third‑party remote access) and prefer a common vendor for adjacent privileged access capabilities The vendor also offers Vendor Privileged Access Management (VPAM) and Customer Privileged Access Management (CPAM) as adjacent components within the broader Privileged Access Security portfolio. These adjacent offerings are relevant when third‑party access is a primary risk vector.

Get a comprehensive analysis of Imprivata Privileged Access Management including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Sep 26, 2026

01Common complaints

If the primary requirement is endpoint least privilege and privilege elevation (PEDM) as a core capability — consider vendors focused on endpoint privilege management.
If the requirement is the broadest enterprise PAM ecosystem and marketplace integrations for large legacy environments — evaluate enterprise benchmark vendors with proven track records in large infrastructure estates.
If the main need is developer‑focused secrets management for applications and CI/CD pipelines — consider dedicated secrets management platforms.
If the organization cannot absorb additional costs for managed services or premium support and requires a low‑touch, self‑service pricing model — evaluate alternative vendors or managed service providers that match the desired operating model.

Deal disqualifiers (poor fit)

Organizations that require full endpoint privilege elevation and delegation management (PEDM) within the same product
Organizations seeking transparent, self‑serve SaaS pricing with month‑to‑month purchasability
DevOps teams that prioritize developer‑centric secrets automation in CI/CD and Kubernetes without additional integration

Limitations noted in third‑party material

Roadmap visibility

The vendor publishes public roadmap materials that can provide signals about planned capabilities. Public roadmaps are marketing‑level artifacts and are not contractual commitments.

Practical operational limitations (inferred from community discussions)

Complex environments (VDI, shared workstations, healthcare kiosks) can require careful policy tuning and troubleshooting to reach stable operations.

Why some customers left for competitors (churn reasons)

Direct public examples of churn from Imprivata PAM to specific competitors were not found in the accessible sources. Typical drivers in the PAM category (based on broader market patterns) include:

Need for more extensive privileged session management, endpoint privilege elevation, or comprehensive secrets automation
Preference for cloud‑native, developer‑centric secrets management
Cost and perceived mismatch between price and scope

02Why they buy

Differentiation supported by market evidence

Vendor presence in healthcare identity and workstation workflows provides operational continuity for organizations already standardized on the vendor’s identity products.
Portfolio coverage that includes internal PAM plus vendor/third‑party access products can reduce the need to integrate multiple vendors to address both internal and external privileged access.

Areas where competitors may have advantages

CyberArk: enterprise breadth and marketplace ecosystem
BeyondTrust / other vendors: stronger endpoint privilege elevation and delegation management capabilities

Why customers chose this product over alternatives (inferred)

Buyers in healthcare ecosystems may prefer a vendor already used for identity workflows and extend to PAM for credential management rather than adopting a separate PAM vendor.
Buyers with significant third‑party access requirements may value the vendor’s VPAM/CPAM adjacency.

Note: these inferences are based on product portfolio alignment and public messaging; direct comparative quotes from customers were not consistently available.

03Field reports

Review platform availability note

What positive feedback tends to emphasize

Fit with healthcare operational workflows: community signals related to Imprivata’s broader identity products suggest perceived operational suitability in hospital and shared workstation contexts.
Relatively straightforward deployment and a short trial offering: vendor materials and some user commentary indicate deployments may be quicker than some larger PAM suites, which can be a procurement consideration for organizations needing faster time to initial capability.
Value of portfolio adjacency for vendor access: organizations that need both internal PAM and vendor/third‑party access controls may see value in a common vendor portfolio that covers both use cases.

Common criticisms and complaints (from accessible discussions)

Integration and configuration complexity in virtual desktop or shared workstation environments (Kerberos, keytab configuration, client/service state issues).
Support and managed services cost sensitivity reported in community discussions; managed services may represent a meaningful additional cost.
Perception by some reviewers that pricing can be high relative to the provided scope when the expectation is for a broader feature set (for example, session management or endpoint privilege elevation in a single product).

Vendor‑published case studies

Critical evaluation: use these materials as indicative of customer experience in similar contexts, but validate claimed outcomes through reference checks and operational metrics where possible.

Ecosystem case studies (VPAM / privileged access security)

04Best fit

Company sizes

Industries / verticals

Healthcare providers and healthcare IT vendors
Other regulated industries (government, legal, financial services, etc.) where auditable privileged credential controls are required

Roles and personas

CISO / Head of Security
IAM/PAM program owner
Infrastructure / security engineering teams
Compliance and audit teams
Vendor/third‑party risk and vendor management teams (for VPAM/CPAM use cases)

Qualification criteria (good fit)

Organizations that already use the vendor for adjacent identity or workstation workflows and wish to consolidate vendors
Organizations that require auditable credential controls (rotation, workflows) and prefer a comparatively straightforward operational model
Deployments where third‑party vendor access governance is a major driver and the vendor’s VPAM/CPAM modules are relevant

05The pitch

What the product does (core value proposition)

Key capabilities emphasized in vendor materials include:

Privileged credential discovery and inventory
Secure vaulting and automated password rotation
Just‑in‑time and time‑bound access workflows
Credential checkout workflows and one‑time‑use credential generation
Monitoring and auditing of privileged activity (reporting depth varies by module)
Alignment with Zero Trust concepts (policy enforcement and auditability)

Target market and market positioning

Imprivata has a history of deployments in healthcare identity workflows (badge tap, fast user switching, clinician workstation workflows). The PAM product is positioned for:

Healthcare and other regulated industries that require auditable control of privileged credentials
Organizations seeking a PAM solution that vendors describe as relatively straightforward to deploy compared with larger enterprise suites
Environments that also require vendor privileged access (third‑party remote access) and prefer a common vendor for adjacent privileged access capabilities

The vendor also offers Vendor Privileged Access Management (VPAM) and Customer Privileged Access Management (CPAM) as adjacent components within the broader Privileged Access Security portfolio. These adjacent offerings are relevant when third‑party access is a primary risk vector.

Get a comprehensive analysis of Imprivata Privileged Access Management including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →